bpc-157 not approved for human use regulatory authority statement Peptides Lack Reliable Safety Information, Watchdog Warns BPC-157 FDA Approval Status: Is
Description
It's simpler than it looks, and we'll walk through it
GHS peptides may also cause fluid retention in the hands, feet, and ankles
Common signs may include lethargy, loss of appetite, and reduced weight gain
Changes in neurosteroidogenesis during demyelination and remyelination in cuprizone-treated mice
Fukushima K, Badlani N, Usas A, Riano F, Fu F, Huard J
Therefore, at the very least, benefits from behavioral change occur across societal levels
